JP2015518829A5 - - Google Patents

Info

Publication number

JP2015518829A5

JP2015518829A5 JP2015512763A JP2015512763A JP2015518829A5 JP 2015518829 A5 JP2015518829 A5 JP 2015518829A5 JP 2015512763 A JP2015512763 A JP 2015512763A JP 2015512763 A JP2015512763 A JP 2015512763A JP 2015518829 A5 JP2015518829 A5 JP 2015518829A5

Authority

JP

Japan

Prior art keywords

lingo

antibody

pharmaceutical composition

antigen

binding fragment

Prior art date

2013-05-14

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Withdrawn

Links

• Espacenet
• Global Dossier
• Discuss

• 239000012634 fragment Substances 0.000 claims description 69
• 230000027455 binding Effects 0.000 claims description 62
• 239000000427 antigen Substances 0.000 claims description 58
• 102000036639 antigens Human genes 0.000 claims description 58
• 108091007433 antigens Proteins 0.000 claims description 58
• 210000002161 motor neuron Anatomy 0.000 claims description 30
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 23
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 17
• 229920001184 polypeptide Polymers 0.000 claims description 16
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 16
• 230000032405 negative regulation of neuron apoptotic process Effects 0.000 claims description 11
• 102000039446 nucleic acids Human genes 0.000 claims description 9
• 108020004707 nucleic acids Proteins 0.000 claims description 9
• 150000007523 nucleic acids Chemical class 0.000 claims description 9
• 239000005557 antagonist Substances 0.000 claims description 7
• 241000282414 Homo sapiens Species 0.000 claims description 5
• 238000000034 method Methods 0.000 claims description 4
• 210000004027 cell Anatomy 0.000 claims description 3
• 239000008194 pharmaceutical composition Substances 0.000 claims 33
• 239000013598 vector Substances 0.000 claims 17
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 12
• 241000124008 Mammalia Species 0.000 claims 9
• 201000010099 disease Diseases 0.000 claims 7
• 208000027418 Wounds and injury Diseases 0.000 claims 5
• 230000006378 damage Effects 0.000 claims 5
• 208000035475 disorder Diseases 0.000 claims 5
• 208000014674 injury Diseases 0.000 claims 5
• 230000001737 promoting effect Effects 0.000 claims 5
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims 4
• 230000003376 axonal effect Effects 0.000 claims 3
• 239000000203 mixture Substances 0.000 claims 3
• 208000002320 spinal muscular atrophy Diseases 0.000 claims 3
• 230000004083 survival effect Effects 0.000 claims 3
• 239000013603 viral vector Substances 0.000 claims 3
• 108010047041 Complementarity Determining Regions Proteins 0.000 claims 2
• 208000010366 Postpoliomyelitis syndrome Diseases 0.000 claims 2
• 208000032319 Primary lateral sclerosis Diseases 0.000 claims 2
• 206010046298 Upper motor neurone lesion Diseases 0.000 claims 2
• 239000003937 drug carrier Substances 0.000 claims 2
• 201000006517 essential tremor Diseases 0.000 claims 2
• 208000008675 hereditary spastic paraplegia Diseases 0.000 claims 2
• 201000010901 lateral sclerosis Diseases 0.000 claims 2
• 208000005264 motor neuron disease Diseases 0.000 claims 2
• 230000000750 progressive effect Effects 0.000 claims 2
• 206010002027 Amyotrophy Diseases 0.000 claims 1
• 206010006542 Bulbar palsy Diseases 0.000 claims 1
• 241000701044 Human gammaherpesvirus 4 Species 0.000 claims 1
• 208000023105 Huntington disease Diseases 0.000 claims 1
• 206010033799 Paralysis Diseases 0.000 claims 1
• 208000018737 Parkinson disease Diseases 0.000 claims 1
• 241000700584 Simplexvirus Species 0.000 claims 1
• 241000194017 Streptococcus Species 0.000 claims 1
• 241000700618 Vaccinia virus Species 0.000 claims 1
• 210000003169 central nervous system Anatomy 0.000 claims 1
• 230000001684 chronic effect Effects 0.000 claims 1
• 230000000295 complement effect Effects 0.000 claims 1
• 238000012258 culturing Methods 0.000 claims 1
• 238000001802 infusion Methods 0.000 claims 1
• 238000002347 injection Methods 0.000 claims 1
• 239000007924 injection Substances 0.000 claims 1
• 238000004519 manufacturing process Methods 0.000 claims 1
• 230000001537 neural effect Effects 0.000 claims 1
• 201000002241 progressive bulbar palsy Diseases 0.000 claims 1
• 201000000196 pseudobulbar palsy Diseases 0.000 claims 1
• 230000028600 axonogenesis Effects 0.000 description 10
• 150000001413 amino acids Chemical class 0.000 description 7
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 5
• 241000288906 Primates Species 0.000 description 4
• 102000040430 polynucleotide Human genes 0.000 description 4
• 108091033319 polynucleotide Proteins 0.000 description 4
• 239000002157 polynucleotide Substances 0.000 description 4
• 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 3
• 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 3
• 102000013463 Immunoglobulin Light Chains Human genes 0.000 description 3
• 108010065825 Immunoglobulin Light Chains Proteins 0.000 description 3
• 241000699666 Mus <mouse, genus> Species 0.000 description 3
• 102000004169 proteins and genes Human genes 0.000 description 3
• 108090000623 proteins and genes Proteins 0.000 description 3
• 241000699670 Mus sp. Species 0.000 description 2
• 238000010494 dissociation reaction Methods 0.000 description 2
• 230000005593 dissociations Effects 0.000 description 2
• 238000006467 substitution reaction Methods 0.000 description 2
• ZNVLEAPAWPQEIC-UHFFFAOYSA-N 6-aminoquinoline-5,8-dione Chemical group C1=CC=C2C(=O)C(N)=CC(=O)C2=N1 ZNVLEAPAWPQEIC-UHFFFAOYSA-N 0.000 description 1
• 238000012286 ELISA Assay Methods 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• 150000001720 carbohydrates Chemical class 0.000 description 1
• 230000009137 competitive binding Effects 0.000 description 1
• 230000002860 competitive effect Effects 0.000 description 1
• 230000006957 competitive inhibition Effects 0.000 description 1
• 230000005764 inhibitory process Effects 0.000 description 1
• 230000012846 protein folding Effects 0.000 description 1